Bio-Rad Laboratories

Bio-Rad Laboratories agreed to acquire all shares of Curiosity Diagnostics from Scope Fluidics for up to $170 million, including $100 million in cash and up to $70 million in milestone payments. Curiosity Diagnostics is developing a rapid PCR system for molecular diagnostics.

Bio-Rad Laboratories was awarded a contract by the USDA Food Safety and Inspection Service for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System.

Bio-Rad and Illumina launched the Illumina Bio-Rad Single-Cell Sequencing Solution, announced during the J.P. Morgan Healthcare Conference.

Bio-Rad Laboratories announced it will acquire RainDance Technologies for an undisclosed sum, with the deal expected to close at the end of Q1 2017.